Efficacy of recombinant erythropoietin in the critically ill

被引：0
|
作者：
Corwin, HL [1 ]
Gettinger, A [1 ]
机构：
[1] Dartmouth Hitchcock Med Ctr, Dept Anesthesiol, Lebanon, NH 03766 USA
来源：
INTENSIVE CARE MEDICINE | 2002年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
620
引用
收藏
页码：S160 / S160
页数：1
相关论文
共 50 条
  • [31] Alternatives to blood product transfusion in the critically ill: Erythropoietin
    Stubbs, JR
    [J]. CRITICAL CARE MEDICINE, 2006, 34 (05) : S160 - S169
  • [32] Erythropoietin and renin as biological markers in critically ill patients
    Fabienne Tamion
    Véronique Le Cam-Duchez
    Jean-François Menard
    Christophe Girault
    Antoine Coquerel
    Guy Bonmarchand
    [J]. Critical Care, 8
  • [33] Erythropoietin for critically ill trauma patients: A missed opportunity?
    Corwin, Howard L.
    Napolitano, Lena M.
    [J]. JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2014, 77 (05): : 774 - 779
  • [34] Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients
    MacLaren, R
    Sullivan, PW
    [J]. VALUE IN HEALTH, 2005, 8 (02) : 105 - 116
  • [35] The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study
    Al Sulaiman, Khalid
    Aljuhani, Ohoud
    Korayem, Ghazwa B.
    Altebainawi, Ali F.
    Vishwakarma, Ramesh
    Alfaifi, Mashael
    Alsohimi, Samiah
    Alrayes, Aljoharah
    Albishi, Sara
    Alqahtani, Reem
    Alalawi, Mai
    Al Sulaihim, Ibrahim
    Alanazi, Thamer A.
    Alqahtani, Rahaf A.
    Almagthali, Alaa
    Jomah, Shahamah
    Alshlowi, Areej
    Alshammari, Tahani R.
    Alzahrani, Shahad S.
    Abdulqader, Marwa I.
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
  • [36] Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]
    Georgopoulos, D
    Matamis, D
    Routsi, C
    Michalopoulos, A
    Maggina, N
    Dimopoulos, G
    Zakynthinos, E
    Nakos, G
    Thomopoulos, G
    Mandragos, K
    Maniatis, A
    [J]. CRITICAL CARE, 2005, 9 (05): : R508 - R515
  • [37] The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study
    Al Sulaiman, Khalid
    Aljuhani, Ohoud
    Korayem, Ghazwa B.
    Altebainawi, Ali F.
    Vishwakarma, Ramesh
    AlFaifi, Mashael
    Alsohimi, Samiah
    Alrayes, Aljoharah
    Albishi, Sara
    Alqahtani, Reem
    Alalawi, Mai
    Al Sulaihim, Ibrahim
    Alanazi, Thamer A.
    Alqahtani, Rahaf A.
    Almagthali, Alaa
    Jomah, Shahamah
    Alshlowi, Areej
    Alshammari, Tahani R.
    Alzahrani, Shahad S.
    Abdulqader, Marwa I.
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
  • [38] Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]
    Dimitris Georgopoulos
    Dimitris Matamis
    Christina Routsi
    Argiris Michalopoulos
    Nina Maggina
    George Dimopoulos
    Epaminondas Zakynthinos
    George Nakos
    George Thomopoulos
    Kostas Mandragos
    Alice Maniatis
    [J]. Critical Care, 9
  • [39] Usefulness of autologous transfusion and erythropoietin in surgical and critically ill patients
    Gómez, MM
    Abeigón, EN
    Garrigues, AC
    Ramírez, GR
    [J]. MEDICINA CLINICA, 2003, 120 (09): : 357 - 358
  • [40] Anemia and blood transfusion in the critically ill patient: role of erythropoietin
    Corwin, HL
    [J]. CRITICAL CARE, 2004, 8 (Suppl 2): : S42 - S44
12345